摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

8-chloro-6-phenyl-4H-<1,24>triazolo<4,3-a><1,5>benzodiazepin-5(6H)-one | 54705-80-5

中文名称
——
中文别名
——
英文名称
8-chloro-6-phenyl-4H-<1,24>triazolo<4,3-a><1,5>benzodiazepin-5(6H)-one
英文别名
8-chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-5(6H)-one;8-chloro-6-phenyl-6H-benzo[b][1,2,4]triazolo[4,3-d][1,4]diazepin-5-one;8-Chloro-6-phenyl-4H-s-triazolo[4,3-a][1,5]benzodiazepine-5(6H)one;8-chloro-4,6-dihydro-6-phenyl-5H-S-triazolo[4,5-a][1,5]benzodiazepin-5-one;8-chloro-6-phenyl-4H-s-triazolo[4,3-a][1,5]benzodiazepin-5-one;8-chloro-6-phenyl-4H-s-triazolo[4,3-a][1,5]benzodiazepine-5(6H)-one;8-chloro-6-phenyl-4H-[1,2,4]triazolo[3,4-d][1,5]benzodiazepin-5-one
8-chloro-6-phenyl-4H-<1,24>triazolo<4,3-a><1,5>benzodiazepin-5(6H)-one化学式
CAS
54705-80-5
化学式
C16H11ClN4O
mdl
——
分子量
310.743
InChiKey
UGEUMTVHERRWND-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    22
  • 可旋转键数:
    1
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    51
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    1,5-Benzodiazepines XI. 5-(Dialkylamino) or 5-(alkylthio) substituted 8-chloro-6-phenyl-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepines with anticonvulsant activity
    摘要:
    The cyclocondensation of (dimethylamino)benzodiazepinones 3a,b with hydrazides yielded triazolobenzodiazepinones 4 which were treated with Lawesson's reagent to give thiolactams 5. The phase-transfer catalyzed (TEBA) alkylation of compounds 5 with suitable alkyl halides afforded 5-(alkylthio)-6-phenyl-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepines 6a-f. The desired N,N-dialkyl-6-phenyl-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-5-amines 7a-k were finally obtained from the reaction of the (methylthio)derivatives 6a-d with proper dialkylamines. Compounds 6b-f and 7a-e, g-k were screened for anticonvulsant activity after a preliminary evaluation of their gross behavioral effects and acute toxicity. Nine of the 15 triazolobenzodiazepines tested exerted a clear-cut anticonvulsant effect associated with low acute toxicity. In particular, the most active compounds 6e, f and 7h showed LD50/ED50 ratios that were notably higher than that of phenobarbital and ranging from 50% to 20% of that of diazepam, the latter used as reference drugs.
    DOI:
    10.1016/0223-5234(93)90088-v
  • 作为产物:
    参考文献:
    名称:
    S-triazolo-1,5-benzodiazpine-4-ones
    摘要:
    选择自公式组中的一种s-三唑并[1,5]苯二氮平-4-酮化合物:##STR1## 其中R.sub.o是氢,1至3个碳原子的包括烷基,羟基,羟甲基和##STR2## 其中R"和R'"是氢或上述定义的烷基,或者一起##STR3## 选自吡咯烷基,哌啶基,吗啉基和N-甲基哌嗪基;其中R是氢,1到3个碳原子的包括烷基和##STR4## 其中R"和R'"是上述定义的氢或烷基,或者一起##STR5## 定义如上;其中R.sub.1是氢或甲基;其中R.sub.2、R.sub.3、R.sub.4和R.sub.5选自氢,上述定义的烷基,卤素,硝基,三氟甲基和烷硫基,其中烷基的定义如上,通过与公式(11A)的相应4-肼基-2H-1,5-苯并二氮平-2-酮反应得到,##STR6## 其中R.sub.1、R.sub.2、R.sub.3、R.sub.4和R.sub.5具有上述含义,使用乙酸氯或如果R.sub.o是氢,则使用乙酸乙酯酸酐,并加热至高温以得到相应的4H-s-三唑并[4,3-a][1,5]苯二氮平-5(6H)-酮,通过其他步骤可以将其转化为由公式111A呈现的各种化合物。公式111B的化合物最好通过将4-硫代-1H-1,5-苯并二氮平-2,4-(3H,5H)-二酮(1A)##STR7## 与选择的卡巴曲特反应,然后加热至高温水平。需要额外的步骤来合成由公式111B呈现的各种化合物。公式111A和111B的新化合物具有镇静和催眠活性。
    公开号:
    US04075202A1
点击查看最新优质反应信息

文献信息

  • 4H-S-Triazolo[4,3-2][1,5]benzodiazepin-5-ones
    申请人:E. R. Squibb & Sons, Inc.
    公开号:US04133809A1
    公开(公告)日:1979-01-09
    Compounds of the following formula ##STR1## are useful as central nervous system depressants, tranquilizers, sedatives, growth promotors, anti-convulsants and muscle relaxants in mammalian species.
    以下式的化合物对哺乳动物物种具有镇静剂、镇定剂、安眠剂、生长促进剂、抗惊厥剂和肌肉松弛剂的作用。
  • US4075202A
    申请人:——
    公开号:US4075202A
    公开(公告)日:1978-02-21
  • US4111934A
    申请人:——
    公开号:US4111934A
    公开(公告)日:1978-09-05
  • US4133809A
    申请人:——
    公开号:US4133809A
    公开(公告)日:1979-01-09
  • US4164498A
    申请人:——
    公开号:US4164498A
    公开(公告)日:1979-08-14
查看更多

同类化合物

叔-丁基3-溴-8,9-二氢-5H-[1,2,4]三唑并[4,3-D][1,4]二氮杂卓-7(6H)-甲酸基酯 叔-丁基3-(羟甲基)-7,8-二氢-4H-[1,2,3]三唑并[1,5-A][1,4]二氮杂卓-5(6H)-甲酸基酯 乙基4-(4H-[1,2,4]三唑并[4,3-a][1,5]苯并二氮卓-5-基)哌嗪-1-羧酸酯 9H-[1,2,4]三唑并[4,3-a][1,4]二氮杂卓 9-氯-5,6-二氢-4-甲基-1-(2-噻吩基)-4H-[1,2,4]三唑并[4,3-a][1,5]苯并二氮杂卓 9-氯-1-(2-呋喃基)-5,6-二氢-4-甲基-4H-[1,2,4]三唑并[4,3-a][1,5]苯并二氮杂卓 8-氯-5-(4-甲基哌嗪-1-基)-6-苯基-[1,2,4]三唑并[4,3-a][1,5]苯并二氮杂卓 8-氯-1-甲基-5-(甲基硫烷基)-6-苯基-6H-[1,2,4]三唑并[4,3-a][1,5]苯并二氮卓 2-[(8-氯-6-苯基-6H-[1,2,4]三唑并[4,3-a][1,5]苯并二氮卓-5-基)硫烷基]-N,N-二甲基乙胺 2-[(8-氯-1-甲基-6-苯基-[1,2,4]三唑并[4,3-a][1,5]苯并二氮杂卓-5-基)硫基]-N,N-二甲基乙胺 1H-环丙并[d][1,2,4]三唑并[4,3-b]哒嗪 1H,5H-[1,2,4]三唑并[1,2-a][1,2]二氮杂卓-1,3,5(2H)-三酮,6,9-二氢-2,7-二甲基-9-(2-吡啶基)- (9ci)-1H-1,2,4-噻唑并[4,3-c][1,3]二氮杂卓 (9ci)-1H-1,2,4-噻唑并[4,3-a][1,4]二氮杂卓 3-(Trifluoromethyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-D][1,4]diazepine [1,4-dioxy-3-(pyrrolidine-1-carbonyl)-quinoxalin-2-ylmethylene]-hydrazinecarboxylic acid methyl ester 2-methyl-hexahydro-6-thia-2,3a,7c-triaza-4,4e-cyclo-cyclopenta[1,3]cyclopropa[1,2-a]cyclopropa[cd]-as-indacene-1,3-dione 2-methyl-6,6-dioxo-octahydro-6λ6-thia-2,3a,7c-triaza-4,4e-cyclo-cyclopenta[1,3]cyclopropa[1,2-a]cyclopropa[cd]-as-indacene-1,3-dione (4as,4a1r,8aR,13aS)-11-methyldodecahydro-10H-heptaleno[1',10':3,4,5]pyrazolo[1,2-a][1,2,4]triazole-10,12(11H)-dione 8-chloro-1-methyl-6-phenyl-4H-<1,2,4>triazolo<4,3-a><1,5>benzodiazepine-5(6H)-thione N-methyl-4-oxa-8,9,13-triazaheptacyclo<9.5.1.02,6.02,10.06,14.07,12.013,17>heptadecane-8,9-dicarboximide 8-(octyloxy)-4,5-dihydrobenzo[b][1,2,4]triazolo[4,3-d][1,4]thiazepine 1,3,4-trimethyl-7-oxy-8-phenyl-4,6-dihydro-1H-pyrazolo[4,3-e][1,4]diazepin-5-one 7-methyl-6,7-dihydro-5H-benzo[f][1,2,4]triazolo[4,3-d][1,4]diazepine 1-methyl-6-phenyl-4,6-dihydro-benzo[b][1,2,4]triazolo[4,3-d][1,4]diazepin-5-one 4,4-dimethyl-10-phenyl-hexahydro-1,7;2,6-dicyclo-dicyclobuta[c,e]cyclopenta[d][1,2,4]triazolo[1,2-a]pyridazine-9,11-dione 2-[3-[(3,4-dichlorophenyl)methyl]-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-N-(oxan-4-yl)-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-amine 3-{5H,6H,8H-[1,2,4]triazolo[3,4-c][1,4]oxazin-3-yl}azetidine,bis(trifluoroaceticacid) 1-cyclohexyl-4-methyl-5,6-dihydro-4H-benzo[b][1,2,4]triazolo[4,3-d][1,4]diazepine 8-chloro-1-cyclohexyl-4-methyl-5,6-dihydro-4H-benzo[b][1,2,4]triazolo[4,3-d][1,4]diazepine 2-phenyl-4-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)-3H-benzo[b][1,4]diazepine (1α,7α,8β,11β)-syn-14-acetamido-4-methyl-2,4,6-triazatetracyclo<5.4.2.18,11.02,6>tetradecane-3,5-dione 9-chloro-1-(2,4-dichloro-phenyl)-4-methyl-5,6-dihydro-4H-benzo[b][1,2,4]triazolo[4,3-d][1,4]diazepine 12-(Hydroxyimino)-5-methyl-3,5,7-triazahexacyclo<7.5.02,13.03,7.08,11.010,14>tetradecane-4,6-dione 4-(benzyloxy)-1-methyl-8-chloro-6-phenyl-4H-s-triazolo[4,3-a][1,5]benzodiazepin-5-one 4-((R)-3-morpholin-4-yl-1-phenylsulfanylmethyl-propylamino)-N-(5,6,7,8-tetrahydro-4H-1,2,3a,6-tetraaza-azulen-3-yl)-3-trifluoromethanesulfonyl-benzenesulfonamide 7-[5-chloro-4-(1-methyl-1H-benzimidazol-2-yl)pyridin-2-yl]-3-cyclopropyl-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-d][1,4]diazepine tert-butyl 4-[(1R)-1-({[(6S)-6-(5-chloro-2-methoxybenzyl)-3,7-dioxo-6,7-dihydro-5H-[1,2,4]oxadiazolo[4,3-a][1,4]diazepin-8(9H)-yl]carbonyl}amino)propyl]-2-nitrobenzoate (32Z,51Z,71Z)-35,55,74-trimethyl-1(1,3)-benzena-3,5,7(1,3)-tricyclopentanacyclooctaphane-32,34,51,53,71,74-hexaene 7-methyl-4b,4c,4d,4e,5,8b-hexahydro-5a,7,8a-triaza-4a,5-cyclo-benzo[1,3]cyclopropa[1,2-a]cyclopropa[cd]-as-indacene-2,6,8-trione 2-[3-(2,4-Dibromo-phenyl)-5-phenyl-3H-[1,3,4]thiadiazol-(2E)-ylidene]-pentan-3-one 8-chloro-6-(2-chloro-phenyl)-1-methyl-4,6-dihydro-benzo[b][1,2,4]triazolo[4,3-d][1,4]diazepin-5-one 5-methyl-3,5,7-triazahexacyclo<7.5.0.02,13.03,7.08,11.010,14>tetradecane-4,6,12-trione 6,6a,6b,7,8,10,12a,12b-octahydro-2H,5H-bis[1,2,4]triazolo[4,3-a;4',3'-a']cyclobuta[1,2-c;3,4-e']dipyridine-3,11-dione 4-(3-aminopropyl)-1-methyl-8-chloro-6-phenyl-4H-s-triazolo-[4,3-a][1,5]benzodiazepin-5-one